Company intelligence / Profile preview

Wang On Group

Kowloon Bay, Hong Kongwanggroup.stanford.edu ↗

Ownership: Private
Employees: ~2005
Development stage: Other

Overview

Wang On Group is a diversified conglomerate with active operations in property development/investment, wet market management, financial services, and pharmaceuticals. Its pharmaceutical division operates through Wai Yuen Tong Medicine Holdings Limited—producing both western medicines and traditional Chinese remedies. The group has invested heavily in GMP-certified manufacturing facilities for these products. Their brands are well-established regionally with international reach.

Therapeutic areas: OtherPulmonology
Modalities: Small moleculeTraditional Chinese medicine
Industry: Biotech

Beyond the preview

Go deeper on Wang On Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wang On Group.

Explore the full profile